Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to AML
Related studies linked through entity extraction aliases.
Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study in RAD 001 Patients With Relapse AML
- Status
- COMPLETED
- Phase
- PHASE1
Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Umbilical Cord Blood Transplant for Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)
- Status
- COMPLETED
- Phase
- PHASE3
Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)
- Status
- COMPLETED
- Phase
- PHASE2
STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders
- Status
- COMPLETED
- Phase
- PHASE1
Induction With or Without Granulocyte Colony-Stimulating Factor in AML Transplantation in AML
- Status
- COMPLETED
- Phase
- PHASE3
Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI)
- Status
- UNKNOWN
- Phase
- PHASE2
A Clinical Trial of Cytotoxic T Cells Augmenting Autologous Hematopoietic Stem Cell (AHSC) Transplantation for Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML
- Status
- COMPLETED
- Phase
- PHASE2
Sirolimus in Combination With MEC in High Risk Myeloid Leukemias
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5
- Status
- COMPLETED
- Phase
- PHASE2
Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
High-Dose Imatinib for Relapsed/Refractory c-Kit Positive Acute Myelogenous Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Treatment Outcome in Elderly Patients
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders
- Status
- COMPLETED
- Phase
- N/A